De Angelis P M, Stokke T, Thorstensen L, Lothe R A, Clausen O P
Norwegian National Hospital, Institute for Pathology/University of Oslo, Norway.
Mol Pathol. 1998 Oct;51(5):254-61. doi: 10.1136/mp.51.5.254.
Spontaneous apoptosis and expression of the apoptotic regulatory proteins Bax, Bcl-x, and Bcl-2 were investigated in 50 colorectal carcinomas. The p53 genotypes/phenotypes and BAX genotypes were also determined, and possible associations of these with apoptosis and/or with expression of the different apoptotic regulatory proteins were studied.
Terminal deoxynucleotidyl transferase (TdT) mediated dUTP labelling of DNA fragments was used to detect apoptotic tumour cells in sections and peroxidase immunohistochemistry was used to assess protein expression. p53 genotype/phenotype was determined using constant denaturant gel electrophoresis/immunoblotting and bax genotype was determined using polymerase chain reaction based methods.
The distribution of tumour apoptotic indices was bimodal with a natural cut off at 1.0% (range, 0.0-5.4%); the median fraction of apoptotic tumour cells was 0.8%. Tumour apoptosis was not associated significantly with tumour DNA ploidy status. Normal mucosal tissue had less than 0.1% apoptotic cells. Staining intensities for Bax, Bcl-x, and Bcl-2 were strong; that is, equivalent to or greater than positive normal mucosal cells, in 11 of 50, 20 of 49, and 20 of 48 carcinomas. Frameshift mutations in the bax gene were detected in three of 42 tumours analysed, all of which were DNA diploid, and Bax protein expression in these tumours was absent or very low. Bax, Bcl-x, and Bcl-2 protein expression were not correlated with tumour apoptosis or tumour DNA ploidy status. p53 was expressed in 34 of 50 tumours and p53 gene mutations were detected in 22 of 29 p53 positive tumours analysed. Apoptosis was significantly lower in a greater number of p53 positive tumours than p53 negative tumours. In addition, Bcl-2 protein expression was significantly higher in a greater number of p53 positive tumours compared with p53 negative tumours. Bax and Bcl-x protein expression were not significantly associated with p53 phenotype/genotype.
The results indicate that acquisition of a p53 phenotype is associated with lower spontaneous apoptosis and higher expression of Bcl-2. The results also suggest that p53 is not a major determinant for Bax expression in colorectal carcinomas in vivo.
研究50例结直肠癌中自发凋亡情况以及凋亡调节蛋白Bax、Bcl-x和Bcl-2的表达。同时确定p53基因型/表型和BAX基因型,并研究它们与凋亡和/或不同凋亡调节蛋白表达之间的可能关联。
采用末端脱氧核苷酸转移酶(TdT)介导的dUTP标记DNA片段来检测切片中的凋亡肿瘤细胞,并用过氧化物酶免疫组织化学法评估蛋白表达。使用恒定变性剂凝胶电泳/免疫印迹法确定p53基因型/表型,使用基于聚合酶链反应的方法确定bax基因型。
肿瘤凋亡指数分布呈双峰,自然分界点为1.0%(范围0.0 - 5.4%);凋亡肿瘤细胞的中位数比例为0.8%。肿瘤凋亡与肿瘤DNA倍体状态无显著相关性。正常黏膜组织凋亡细胞少于0.1%。50例癌中11例、49例中20例、48例中20例的Bax、Bcl-x和Bcl-2染色强度较强,即等同于或高于正常阳性黏膜细胞。在分析的42例肿瘤中有3例检测到bax基因移码突变,均为DNA二倍体,这些肿瘤中Bax蛋白表达缺失或极低。Bax、Bcl-x和Bcl-2蛋白表达与肿瘤凋亡或肿瘤DNA倍体状态无关。50例肿瘤中有34例表达p53,在分析的29例p53阳性肿瘤中有